Tariff Mitigation Strategies with Braumiller Law Group Managing Partner Adrienne Braumiller
All Things Investigations – Navigating Secondary Tariffs with Mike Huneke and Brent Carlson
Innovation in Compliance: Navigating Regulatory Changes and Compliance in Trade and Data Privacy with Stephanie Font
Wiley's 2025 Key Trade Developments Series: Trade Remedies
Wiley's 2025 Key Trade Developments Series: U.S.-Mexico-Canada Agreement (USMCA)
CHPS Podcast Episode 3: Unlocking America's Mineral Potential
Tariffs and Trade Series: Effects on Agriculture Operations and Markets
Sunday Book Review: April 13, 2025, The Books on Trade and Tariffs Edition
U.S. Introduces “Fair and Reciprocal Plan,” Marking Significant and Impactful Shift in Trade Policy
Insights on the Trump Administration's Agriculture and Food Policy Priorities
Hot Topics in International Trade-Foreign Trade Zone (FTZ) Benefits
Episode 308 -- Gabrielle Griffith, Director BPE Global, on Trade Compliance
Video: Making Trade Inclusive for All Americans: A Conversation with Nicole Breland Aandahl
Braumiller Law Group VP of Marketing, Bob Brewer sits down with BLG Attorney Harold Jackson to discuss anti-dumping and countervailing duties regarding China. They also touch on China trade relations in general with the U.S.
Torres Talks Trade podcast Episode 8 on Worker-Centered Trade
Torres Talks Trade Podcast- Episode 3- Cross-Border Trade Disruptions between Texas and Mexico
Freedom Fund: Looking Towards a Financial NATO
Torres Talks Trade Podcast- Episode 1- Russia Sanctions with Former Commerce Enforcement Agent
Digital Trade: Key Trends and Developments to Watch
Five Questions, Five Answers: The Voice of Canadian Automotive Parts Manufacturers
In April, McDermott gathered more than 100 health and life sciences innovators, investors, business leaders and advisers in Paris for our annual European Health & Life Sciences symposium. With such an esteemed crowd available...more
After months of signaling, the Department of Commerce disclosed on April 14 that it had begun an investigation into the national security impacts of importing pharmaceuticals, pharmaceutical ingredients and derivative...more
As the November elections rapidly approach, Congress faces a number of key legislative deadlines, including the need to fund federal agencies and extend expiring federal programs at the conclusion of the current fiscal year...more
• FDA issues a Proposed Rule to allow states and other entities to import certain prescription drugs from Canada. • In addition, FDA issues draft guidance for industry to explain how drug manufacturers can import their own...more
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our second “Public Policy Weekly* Health Care Newsletter” in which we compile the latest health care policy news and legislation. Please...more